TransMedics Group, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2025: 11.70%

TransMedics Group, Inc. EBIT Margin is 11.70% for the Trailing 12 Months (TTM) ending March 31, 2025, a -1,904.82% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • TransMedics Group, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was -0.65%, a -96.86% change year over year.
  • TransMedics Group, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was -20.62%, a -81.23% change year over year.
  • TransMedics Group, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was -109.85%, a 15.69% change year over year.
  • TransMedics Group, Inc. EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was -94.95%, a -19.38% change year over year.
Key Data
Date EBIT Margin EBITDA Margin Net Income Margin EBT Margin